| 000 | 01709 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517001445.0 | ||
| 264 | 0 | _c20150213 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1543-2165 | ||
| 024 | 7 |
_a10.5858/arpa.2013-0604-OA _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSheffield, Brandon S | |
| 245 | 0 | 0 |
_aHER2/neu testing in gastric cancer by immunohistochemistry: assessment of interlaboratory variation. _h[electronic resource] |
| 260 |
_bArchives of pathology & laboratory medicine _cNov 2014 |
||
| 300 |
_a1495-502 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenes, erbB-2 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunohistochemistry _xmethods |
| 650 | 0 | 4 |
_aIn Situ Hybridization _xmethods |
| 650 | 0 | 4 | _aLaboratories |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aObserver Variation |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aStomach Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aTissue Array Analysis _xmethods |
| 650 | 0 | 4 | _aTrastuzumab |
| 700 | 1 | _aGarratt, John | |
| 700 | 1 | _aKalloger, Steve E | |
| 700 | 1 | _aLi-Chang, Hector H | |
| 700 | 1 | _aTorlakovic, Emina E | |
| 700 | 1 | _aGilks, C Blake | |
| 700 | 1 | _aSchaeffer, David F | |
| 773 | 0 |
_tArchives of pathology & laboratory medicine _gvol. 138 _gno. 11 _gp. 1495-502 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5858/arpa.2013-0604-OA _zAvailable from publisher's website |
| 999 |
_c24317268 _d24317268 |
||